Antiviral Drug Umifenovir Secures Nod for Clinical Trial for COVID-19: CSIR
Umifenovir is mainly used for treatment of influenza and is available in China and Russia, and has recently come into prominence due to its potential use for COVID-19 patients.
No comments:
Post a Comment